Antitumor activity with nontoxic doses of protein A

Summary This report confirms our previous observation that IV inoculation of purified protein A causes regression of rat mammary adenocarcinomas. In treated tumors, we have obtained histological evidence of changes indicating tumor cell destruction. Protein A treatment does not cause reduction in the body weight or organ weights of rats; nor does it cause any decrease in activity of the enzymes of the microsomal mixed function oxidase system in the liver. Protein A stimulates peripheral white cell counts in normal rats, but not in tumor-bearing rats. We found that protein A infusion reduced (P<0.0005) the level of circulating plasma immune complex concentration. A homing study with ¹²⁵I-labeled protein A indicated that liver, spleen, and kidney tissues are the major sites of protein A accumulation. Therefore, protein A seemed to exert its antitumor effects without causing any generalized toxicity to the system. It is postulated that the action of protein A may be related to its ability to cause a drastic reduction in circulating plasma immune complex concentration, thus potentiating the immune reactivity of the host observed earlier.     

Augmentation of the antibody response by hapten help: I. Dominant genetic control

The objective of the present work was to characterize those genetic factors that determine susceptibility to “hapten help,” i.e., the augmentation of B-cell responses by hapten-reactive T cells. After mice had been sensitized to the hapten azobenzenearsonate (ABA), one of two approaches was used to assay hapten help. In the first, circumvention of tolerance to low doses of bovine γ-globulin (BGG) was augmented in CBA but not in C57BL/6 mice, as measured by serum anti-BGG antibody after challenge with ABA-BGG. Second, similar strain differences but on a larger scale were demonstrated in the anti-BGG plaque-forming cell (PFC) response of spleen cells from hapten-primed nontolerized mice after challenge with ABA-BGG. Results with the F1-hybrid of a cross between a high responder and a low responder for hapten help demonstrated that high responsiveness is dominant. Experiments with recombinant inbred mice from high- and low-responder progenitor strains suggested that hapten help is associated not with the major histocompatibility complex (H-2) so much as with minor histocompatibility antigens such as H-22 and/or H-24, both of which are on chromosome 7.     

RNA extracts of lymphoid cells sensitized to DNP-oligolysines convert nonresponder lymphoid cells to responder cells which release migration inhibition factor

Strain 13 nonresponder peritoneal exudate cells were converted to responder status to α or ?,DNP-oligolysines after incubation of the cells with RNA extracts prepared from responder guinea pigs skin test sensitive to these synthetic antigens. The conversion of nonresponder strain 13 cells was assessed by the direct cell migration inhibition correlate of delayed hypersensitivity. Nonresponder cells were not converted by RNA extracts prepared from unimmunized responder guinea pigs or from non-responder strain 13 guinea pigs previously injected with DNP-oligolysines. Thus, it seems possible to correct immunological unresponsiveness in vitro in spite of a specific genetically determined deficiency of the immune response related to the Ir gene.     

Smoothelin-like 2 Inhibits Coronin-1B to Stabilize the Apical Actin Cortex during Epithelial Morphogenesis

1. Download : Download high-res image (216KB)
2. Download : Download full-size image